Visiomed Group SA is a leading company that represents strong values and a robust corporate philosophy. With a focus on innovation, Visiomed Group SA strives to provide cutting-edge medical solutions to improve healthcare outcomes globally. By integrating advanced technology and expertise, the company is dedicated to offering a wide range of innovative medical devices and digital health solutions. Visiomed Group SA prioritizes patient-centric care, ensuring safety, and enhancing the quality of life for individuals. With a commitment to excellence and a customer-oriented approach, Visiomed Group SA aims to revolutionize medical practices and contribute to the advancement of the healthcare industry.

Visiomed Group SA is primarily present in France, where it is headquartered. However, the company has extended its presence to various regions and countries. With its innovative healthcare solutions, Visiomed Group SA's products are trusted and used by individuals across Europe, including countries like Germany, Italy, Spain, and the United Kingdom. Additionally, the company has established a strong presence in several African countries, such as Morocco and Tunisia, as well as in the Middle East, including the United Arab Emirates. Through its global reach, Visiomed Group SA aims to provide accessible and reliable healthcare solutions for people around the world.

Visiomed Group SA, a leading healthcare technology company, has achieved remarkable milestones throughout its history. Recognized for its innovative solutions, the company has successfully introduced groundbreaking medical devices and services to the market. Visiomed Group SA pioneered the development of cutting-edge connected health products such as the award-winning ThermoFlash®, a non-contact infrared thermometer. Additionally, the company launched BewellConnect®, a comprehensive ecosystem of connected health solutions tailored to individuals, healthcare professionals, and organizations. With its commitment to technological advancements and user-friendly healthcare solutions, Visiomed Group SA continues to revolutionize the industry and improve the overall well-being of individuals worldwide.

Visiomed Group SA is a renowned company specializing in medical technology and healthcare. Established in (year), Visiomed Group has built a strong reputation for its innovative solutions that enhance patient care and well-being. The company is dedicated to developing and commercializing cutting-edge medical devices, including connected healthcare products and digital diagnostics. With a commitment to research and development, Visiomed Group has paved the way for advancements in telemedicine and remote patient monitoring. Through its comprehensive product portfolio, Visiomed Group aims to improve access to quality healthcare and empower individuals to take control of their health.

The main competitors of Visiomed Group SA in the market include companies like Omron Healthcare, Philips Healthcare, and Medtronic. These global healthcare players offer similar products and services in the medical technology industry. However, Visiomed Group SA differentiates itself through its innovative range of connected and portable medical devices such as the BewellConnect® ecosystem. With its unique product offerings and focus on enhancing patients' well-being, Visiomed Group SA stays competitive in the market against these formidable rivals.

Visiomed Group SA is primarily active in the healthcare industry.

The business model of Visiomed Group SA focuses on developing and commercializing innovative medical devices and services. As a leading healthcare company, Visiomed Group specializes in connected health solutions that use advanced technology to improve patient monitoring and remote care. With a wide range of smart medical devices, such as smart thermometers and blood pressure monitors, Visiomed Group aims to enhance healthcare management and empower individuals to monitor their health more effectively. By providing cutting-edge products and services, Visiomed Group SA plays a vital role in promoting preventive medicine and digital healthcare solutions.

Klea Holding hissesinin F/K oranı 19,79.

Klea Holding KUV 3,33 dir.

Klea Holding için AlleAktien Kalite Skoru 1/10'dur.

beklenen Klea Holding cirosu 18,85 Milyon. EUR dir.

beklenen Klea Holding karı 3,17 Milyon. EUR olarak gerçekleşmiştir.

The Visiomed Group SA is a French company specialized in digital healthcare solutions. Its business model is focused on providing innovative products and services that contribute to revolutionizing the health technology industry. The company is divided into three different business areas, which include separate subsidiaries: BewellConnect, Vivalink, and BewellConnect Services. BewellConnect focuses on the development of medical devices and health applications, while Vivalink specializes in mobile health services. BewellConnect Services, on the other hand, offers innovative services to research institutions and healthcare professionals. Visiomed's product offering is aimed at meeting the needs of patients and health experts. The company offers a wide range of medical devices and applications, including blood pressure monitors, thermometers, inhalers, and EKG devices. Some of these devices are connected to the internet, allowing users to automatically monitor their health values and share their data with their doctors or other health experts. Another important product from Visiomed is the BewellCheck-up application, which serves as a telemedicine platform that allows users to have virtual consultations with doctors and specialists. The platform also offers online diagnostic services to facilitate the diagnosis of health problems. Additionally, Visiomed also provides its customers with mobile health services. The Vivalink app allows users to manage and share their health data directly from their mobile phones. The application also provides personalized health tips and enables users to access medical advice from specialists. In addition to providing products and services, Visiomed also operates its own research and development department, which continuously works on developing new technologies. The company is also committed to providing sustainable healthcare by developing new solutions that are beneficial for both the patient and the healthcare provider. Overall, the Visiomed Group offers an innovative and diverse range of businesses that address the needs of healthcare technology executives. With its wide range of medical devices, applications, and services, as well as its close collaboration with research institutions and health experts, the company will continue to grow and assert itself in the market of digital healthcare solutions.

Klea Holding, yılda kez dağıtılmak üzere 0 EUR tutarında temettü ödemektedir.

Klea Holding için şu an için temettü hesaplanamıyor veya şirket temettü dağıtmıyor.

Klea Holding şirketinin ISIN kodu FR0013481835’dir.

Klea Holding 'nin WKN'si A2PZ7S 'dir.

Klea Holding için Ticker ALVMG.PA’dir.

Son 12 ay içerisinde Klea Holding, tutarında bir temettü ödedi. Bu, yaklaşık olarak oranında bir temettü verimine denk gelmektedir. Gelecek 12 ay için Klea Holding, tahmini olarak 0 EUR tutarında bir temettü ödemesi yapacak.

Klea Holding şirketinin mevcut temettü verimi .

Klea Holding dönemsel olarak temettü ödemesi yapar. Bu ödemeler aylarında gerçekleştirilir.

Klea Holding, son 0 yıl içerisinde her yıl temettü ödedi.

Önümüzdeki 12 ay için 0 EUR tutarında temettü ödenmesi beklenmektedir. Bu, 0 % oranında bir temettü verimidir.

Klea Holding, 'Sağlık' sektörüne atanmıştır.

Son Klea Holding tarihinde 0 EUR tutarındaki en son temettüyü alabilmek için, hisseyi 09.09.2024 tarihindeki Ex-Tag'den önce portföyünde bulundurman gerekiyordu.

Son ödeme tarihi 09.09.2024 olarak gerçekleşti.

2023 yılında Klea Holding tarafından 0 EUR olarak temettüler dağıtıldı.

Klea Holding hisselerinin temettüleri EUR olarak dağıtılır.